| FROM
THE ARCHIVES OF
RONALD J. RESCIGNO, MD |
| |
BIOGRAPHICAL
SKETCH |
|
| |
SELECTED
ARTICLES |
|
| |
|
|
| |
1. Jabs DA, et al; Studies of Ocular Complications of AIDS Research Group. AIDS and ophthalmology. Arch Ophthalmol 2008;126:1143-6. |
|
| |
|
|
| |
2. Freeman WR, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Vision function in HIV-infected individuals without retinitis; Report of the Studies of Ocular Complications of AIDS Research Group. Am J Ophthalmol 2008;45:453-62. |
|
| |
|
|
| |
3. Jabs DA, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Longitudinal study of the ocular complications of AIDS: 2. Ocular examination results at enrollment. Ophthalmology 2007;114(4):787-93. |
|
| |
|
|
| |
4. Jabs DA, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Longitudinal study of the ocular complications of AIDS: 1. Ocular diagnoses at enrollment. Ophthalmology 2007;114(4):780-6. |
|
| |
|
|
| |
5. Thorne JE, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Effect of cytomegalovirus retinitis on the risk of visual acuity loss among patients with AIDS. Ophthalmology 2007;114(3):591-8. |
|
| |
|
|
| |
6. Thorne JE, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Causes of visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006;113:1441-5. |
|
| |
|
|
| |
7. Thorne JE, et al; Studies of Ocular Complications of AIDS Research Group (Rescigno RJ). Incidence of and risk factors for visual acuity loss among patients with AIDS and cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Ophthalmology 2006;113:1432-40. |
|
| |
|
|
| |
8. Kempen JH et al; Studies of the Ocular Complications of AIDS Research Group. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis. Ophthalmology 2006;113:684-94. |
|
| |
|
|
| |
9. Jabs DA et al; Studies of the Ocular Complications of AIDS Research Grou.: Risk factors for mortality in patients with AIDS in the era of highly active antiretroviral therapy. Ophthalmology 2005;112:771-9. |
|
| |
|
|
| |
10. Landolfi M, Bhagat N, Langer P, Rescigno R, Mirani N, Gass JD, Grigorian RA, Zarbin MA. Penetrating trauma associated with findings of multiple evanescent white dot syndrome in the second eye: coincidence or an atypical case of sympathetic ophthalmia? Retina. 2004; 24(4):637-45. |
|
| |
|
|
| |
11. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K. Li HK; Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 2. Second eye involvement and retinal detachment. Ophthalmology 2004;111:2232-9. |
|
| |
|
|
| |
12. Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K. Li HK; Studies of Ocular Complications of AIDS Research Group. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression. Ophthalmology 2004;111:2224-31 |
|
| |
|
|
| |
13. Dunn, JP, Van Natta M, Foster G, Kuppermann BD, Martin DF, Zaong A, Jabs, DA; Studies of Ocular Complications of AIDS Research Group. Complications of ganciclovir implant surgery in patients with cytomegalovirus retinitis: the Ganciclovir Cidofovir Cytomegalovirus Retinitis Trial. Retina 2004;24:41-50. |
|
| |
|
|
| |
14. Jacobson MA, Maecker HT, Orr PL, D’Amico R, Van Natta M, Li XD Pollard RB, Bredt B; Adult AIDS Clinical Trials Groupand the Studies of Ocular Complications of AIDS Research Group. Results of a CMV-specific CD8+/IFNy+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in AIDS patients with CMV retinitis. J Infect Dis 2004;189:1362-73. |
|
| |
|
|
| |
15. Holbrook JT, Jabs DA, Weinberg DV, Lewis RA, Davis MD, Friedberg D for the Studies of Ocular Complications of AIDS Research Group. Visual loss in patients with cytomegalovirus retinitis and AIDS before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 2003;121(1):99-107. |
|
| |
|
|
| |
16. Kempen JH, Martin BK, Wu A, Barron B, Thorne JE, Jabs DA for the Studies of Ocular Complications of AIDS Research Group. The effect of cytomegalovirus retinitis on the quality of life of patients with acquired immune deficiency syndrome in the era of highly active anti-retroviral therapy. Ophthalmol 2003;110: 987-95. |
|
| |
|
|
| |
17. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. Data and safety monitoring board deliberations resulting in the early termination of the Monoclonal Antibody Cytomegalovirus Retinitis Trial. Control Clin Trials. 2003;24:92-8. |
|
| |
|
|
| |
18. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. Visual loss in patients with cytomegalovirus retinitis and AIDS before widespread availability of highly active antiretroviral therapy. Arch Ophthalmol 2003;121(1):99-107. |
|
| |
|
|
| |
19. Rescigno RJ as member of the Stu dies of the Ocular Complications of AIDS Research Group. The influence of filgrastim (granulocyte colony-stimulating factor) on human immunodeficiency virus type 1 RNA in patients with cytomegalovirus retinitis. J Infect Dis 2002;186:1013-9. |
|
| |
|
|
| |
20. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. HIV and CMV viral load and clinical outcomes in patients with AIDS and CMV retinitis: Monoclonal Antibody Cytomegalovirus Retinitis Trial. AIDS 2002;16(6):877-87. |
|
| |
|
|
| |
21. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. Use of filgrastim (G-CSF) as adjuvant therapy in patients with AIDS-related cytomegalovirus retinitis. AIDS 2002;16(5):757-65. |
|
| |
|
|
| |
22. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. Characteristics of patients with cytomegalovirus retinitis in the era of highly active antiretroviral therapy. Am J Ophthalmol 2002;133: 48-61. |
|
| |
|
|
| |
23. Bielory L, Dinowitz M, Rescigno R. Ocular allergic diseases: differential diagnosis, examination techniques and testing. J Toxicol Cutane Ocul Toxicol 2002;21:329-51. |
|
| |
|
|
| |
24. Rescigno R, Dinowitz
M, Ophthalmic manifestations of imunodeficiency states. Clin Rev
Allergy Immunol 2001;20:2. |
|
| |
|
|
| |
25.
Rescigno RJ as member of the Studies of
the Ocular Complications of AIDS Research Group. Ganciclovir implant
plus oral ganciclovir versus parenteral cidofovir for the treatment
of cytomegalovirus retinitis in patient with AIDS: the ganciclovir
cidofovir cytomegalovirus retinitis trial. Am J Ophthalmol 2001;131:457-67. |
|
| |
|
|
| |
26. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. Photographic measures of cytomegalovirus retinitis as surrogates for visual outcomes in treated patients. Arch Ophthalmol 2001;119:544-563. |
|
| |
|
|
| |
27.
Rescigno RJ as member of the Studies
of the Ocular Complications of AIDS Research Group. Long-term
follow-up of patients with AIDS treated with parenteral cidofovir
for cytomegalovirus retinitis: the HPMPC peripheral cytomegalovirus
retinitis trial. AIDS 2000; 14:1571-1581. |
|
| |
|
|
| |
28. Lama P, Firestone D, Rescigno
R. Syphlitic uveitis in the 1990's. Invest Ophthalmol. Vis
Sci 2000;
41 (Suppl):781. |
|
| |
|
|
| |
29. Dinowitz M, Rescigno R,
Bielory L. Ocular allergic diseases: differential diagnosis, examination
techniques
and testing. Clin Allergy Immun 2000;15:127-50. |
|
| |
|
|
| |
30. Rescigno R. Uveitis
in patients with cytomegalovirus retinitis on intravenous cidofovir.
Ophthalmol Vis Sci 1999; 40 (Suppl):874. |
|
| |
|
|
| |
31.
Rescigno RJ as member of
the Studies of the Ocular Complications of AIDS Research Group.
Parenteral cidofovir for cytomegalovirus retinitis in patients
with AIDS: the HPMPC peripheral cytomegalovirus retinitis trial.
Ann Int Med 1997;126:264-74. |
|
| |
|
|
| |
32. Rescigno RJ as member of the Studies of the Ocular Complications of AIDS Research Group. MSL-109
adjuvant therapy for cytomegalovirus retinitis in patients with
acquired immunodeficiency syndrome. Arch Ophthal 1997; 115:1528-36. |
|
| |
| |
33. Bielory L, Sohn T, Rescigno RJ. Bilateral red eyes in a patient infected with human immunodeficiency virus [clinical conference]. Ann Allergy Asthma Immunol 1995;74:289-93. |
| |
| |
BOOKS AND CHAPTERS |
| |
| |
1. Dinowitz M, Rescigno R, Bielory L. Ocular allergic diseases: differential diagnosis, examination techniques and testing. In: Kemp S, Lockey D, editors. Diagnostic testing of allergic disease. New York: Marcel Dekker; 2000. p 127-150. |
| |
